Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)

Inclusion Criteria:

• Medical diagnosis of Type 2 Diabetes; determined by review of subject-provided mostrecent Hg A1c.

• Subject is under current care of a primary care provider or specialist

• Clearance by medical provider to participate in diet, physical activity, andlifestyle changes

• 18 years and above

• Own a smartphone and be willing to install the Signos App to personally receive textmessages or have access to a web-based survey to self-report their weight.

• Willingness to complete quality of life questionnaires or other in-app surveys.

• Willingness to use CGM device

• Able to speak and read English

• Be a Signos mHealth (mobile/web-based) user

Exclusion Criteria:

• Medical diagnosis of Type 1 Diabetes

• Type 2 Diabetes currently using insulin or most recent A1c ≥10%

• Severe hypoglycemia <54 mg/dl resulting in seizure or unconsciousness, or requiringassistance/EMS/hospitalization - within 3 months prior to enrollment

• Current medical diagnosis of an eating disorder (such as anorexia nervosa orbulimia)

• Medical conditions (e.g., such as seizure disorder) requiring a specific medicaldiet.

• Inborn error of metabolism such as phenylketonuria (PKU), glycogen storage disease,fructose intolerance, Maple Sugar Urine Disease (MSUD).

• History of 10 or more soft tissue skin infections (such as cellulitis or abscesses)

• Intolerable skin reaction from adhesive

• Currently taking any of the following medications: Clozapine, Hydroxyurea, or anyform of insulin.